Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Total Non-Current Liabilities

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
AD     Remove this Ad

MANKIND PHARMA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹7,420 Cr₹187 Cr₹199 Cr₹169 Cr₹107 Cr

What is the latest Total Non-Current Liabilities ratio of MANKIND PHARMA ?

The latest Total Non-Current Liabilities ratio of MANKIND PHARMA is ₹7,420 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹7,420 Cr
Mar2024₹187 Cr
Mar2023₹199 Cr
Mar2022₹169 Cr
Mar2021₹107 Cr

How is Total Non-Current Liabilities of MANKIND PHARMA Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹7,420 Cr
3,860.66
Mar2024 ₹187 Cr
-5.97
Mar2023 ₹199 Cr
18.12
Mar2022 ₹169 Cr
57.15
Mar2021 ₹107 Cr -

Compare Total Non-Current Liabilities of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹85,817.0 Cr 0.9% -6.1% -15.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹411,402.0 Cr 1.2% -0.9% -1.8% Stock Analytics
DIVIS LABORATORIES ₹164,277.0 Cr 2.7% -3.8% 5.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹138,140.0 Cr 2.1% 2.8% 30.9% Stock Analytics
CIPLA ₹107,398.0 Cr -0.1% -8.2% -8.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,378.0 Cr 2.7% 7.1% 2.8% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

0.9%

-6.1%

-15.8%

SENSEX

0.4%

-0.2%

6.9%


You may also like the below Video Courses